Zion Research has published a new report titled “Hba1c Testing Device Market by Device Type (Handheld Device and Bench-top Device) and by Technology Type (Ion-exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay and Other) for Hospitals, Homecare, Diagnostic Laboratory and Research Institutions – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global HbA1c testing device market accounted for around USD 1.20 billion in 2015 and is expected to reach approximately USD 2.20 billion by 2021, growing at a CAGR of around 11 % between 2016 and 2021.

The report covers forecast and analysis for the HbA1c testing device market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the HbA1c testing device market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the HbA1c testing device market on a global level.

Request Free Sample copy of Research Report @ https://www.zionmarketresearch.com/sample/hba1c-testing-device-market

This report offers comprehensive coverage on global HbA1c testing device market along with, market trends, drivers, and restraints of the HbA1c testing device market. This report includes a detailed competitive scenario and technology portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the HbA1c testing device market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.

The study provides a decisive view on the HbA1c testing device market by segmenting the market based on device type, technology type, end user, and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The device type market covered under this study includes handheld device and bench-top device. The technology type based market covered under this study includes ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay and other. The end user type market covered under this study includes hospitals, home care, diagnostic laboratory and research institution. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa.

Browse detail report with in-depth TOC @ https://www.zionmarketresearch.com/report/hba1c-testing-device-market

Key operating players in HbA1c testing device market are like Transasia Biomedicals ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc.